Primary Site >> Liver Cancer
Gene >> HLF
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Inhibition of hepatitis-B-virus core promoter by p53: implications for carcinogenesis in hepatocytes. PMID: 8824564 |
Ref: Induction of apoptosis after switch-on of the hepatitis B virus X gene mediated by the Cre/loxP recombination system. PMID: 10567659 |
Ref: Simple quantitative assay of alpha-fetoprotein mRNA in liver tissue using the real-time detection polymerase chain reaction assay - its application for clinical use. PMID: 11282488 |
Ref: Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines. PMID: 14559815 |
Ref: Apoptosis of liver cancer cells by vitamin K2 and enhancement by MEK inhibition. PMID: 17088989 |
Ref: The growth inhibition of hepatocellular and cholangiocellular carcinoma cells by gemcitabine and the roles of extracellular signal-regulated and checkpoint kinases. PMID: 18813828 |
Ref: Twist expression promotes migration and invasion in hepatocellular carcinoma. PMID: 19615090 |
Ref: Use of protein array technology to investigate receptor tyrosine kinases activated in hepatocellular carcinoma. PMID: 22977516 |
Ref: Hepatocellular and cholangiolar carcinoma-derived cell lines reveal distinct sets of chromosomal imbalances. PMID: 22261732 Ref: Caffeine increases the antitumor effect of Cisplatin in human hepatocellular carcinoma cells. PMID: 22382328 Ref: The expression levels of CD44v6 are correlated with the invasiveness of hepatocellular carcinoma in vitro, but do not appear to be clinically significant. PMID: 22783389 |
Ref: Bortezomib induces tumor-specific cell death and growth inhibition in hepatocellular carcinoma and improves liver fibrosis. PMID: 23011081 Ref: Expression of angiogenic factors in hepatocarcinogenesis: Identification by antibody arrays. PMID: 23970062 |
Ref: Network modeling of TGFbeta signaling in hepatocellular carcinoma epithelial-to-mesenchymal transition reveals joint sonic hedgehog and Wnt pathway activation. PMID: 25189528 Ref: Co-culture of hepatocellular carcinoma cells and human umbilical endothelial cells damaged by SU11274. PMID: 25279148 Ref: Picropodophyllin and sorafenib synergistically suppress the proliferation and motility of hepatocellular carcinoma cells. PMID: 25289088 |
Ref: Smad7 regulates compensatory hepatocyte proliferation in damaged mouse liver and positively relates to better clinical outcome in human hepatocellular carcinoma. PMID: 25602745 Ref: Activation of AMP-activated protein kinase by retinoic acid sensitizes hepatocellular carcinoma cells to apoptosis induced by sorafenib. PMID: 25683251 Ref: Identification of a unique hepatocellular carcinoma line, Li-7, with CD13(+) cancer stem cells hierarchy and population change upon its differentiation during culture and effects of sorafenib. PMID: 25885470 Ref: MicroRNA profiles in cisplatin-induced apoptosis of hepatocellular carcinoma cells. PMID: 26060089 Ref: miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cells. PMID: 26125451 Ref: Induction of active demethylation and 5hmC formation by 5-azacytidine is TET2 dependent and suggests new treatment strategies against hepatocellular carcinoma. PMID: 26366235 |
Ref: Hepatocellular carcinoma cell sensitivity to Vgamma9Vdelta2 T lymphocyte-mediated killing is increased by zoledronate. PMID: 26936487 Ref: An integrin beta4-EGFR unit promotes hepatocellular carcinoma lung metastases by enhancing anchorage independence through activation of FAK-AKT pathway. PMID: 26996299 Ref: A selective splicing variant of hepcidin mRNA in hepatocellular carcinoma cell lines. PMID: 27264950 Ref: HDAC inhibition activates the apoptosome via Apaf1 upregulation in hepatocellular carcinoma. PMID: 27342975 Ref: MicroRNA profiles in various hepatocellular carcinoma cell lines. PMID: 27588118 Ref: Treatment with MAPKAP2 (MK2) inhibitor and DNA methylation inhibitor, 5-aza dC, synergistically triggers apoptosis in hepatocellular carcinoma (HCC) via tristetraprolin (TTP). PMID: 27619201 |
Ref: Promising therapeutic efficacy of a novel reduced expression in immortalized cells/dickkopf-3 expressing adenoviral vector for hepatocellular carcinoma. PMID: 28168749 Ref: 2-Deoxyglucose and sorafenib synergistically suppress the proliferation and motility of hepatocellular carcinoma cells. PMID: 28356961 Ref: Proliferation of sphere-forming hepatocellular carcinoma cells is suppressed in a medium without glucose and arginine, but with galactose and ornithine. PMID: 28454244 Ref: Hepatocyte selection medium-enriched hepatocellular carcinoma cells are positive for alpha-fetoprotein and CD44. PMID: 28693249 Ref: Sporadic PCDH18 somatic mutations in EpCAM-positive hepatocellular carcinoma. PMID: 29075151 |
Ref: Survival pathway of cholangiocarcinoma via AKT/mTOR signaling to escape RAF/MEK/ERK pathway inhibition by sorafenib. PMID: 29251327 Ref: Polymeric Nano-Micelles as Novel Cargo-Carriers for LY2157299 Liver Cancer Cells Delivery. PMID: 29509706 Ref: Galunisertib suppresses the staminal phenotype in hepatocellular carcinoma by modulating CD44 expression. PMID: 29515105 Ref: [Sestrin 2(SESN2) promotes primary resistance to sorafenib by activating AKT in hepatocellular carcinoma cells]. PMID: 30043734 Ref: Liver cancer cell lines distinctly mimic the metabolic gene expression pattern of the corresponding human tumours. PMID: 30176945 |